MKI67 and melanoma: Complementary studies employing melanoma and breast cancer cell lines (70WSM3 and MDA-MB-231BR, respectively) confirmed these results: enhanced cell growth and Ki67 expression positivity were detected when these cells were co-cultured with patient-derived PMN-MDSCs (Figure S3).